Grupo Cibest S.A. · CIB · FY2024 Q3 · Calendar Q4 2024
CIB: Raised loan-growth outlook, with NIM pressure ahead
The supplied analysis supports a cautiously constructive view: improving macro conditions, deposit growth, digital expansion and a new holding structure may support growth, but expected NIM compression, credit risks and the unproven timing of Nequi profitability temper the outlook.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CIB FY2024 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis is more constructive than the prior-quarter analysis: management raised loan-growth guidance, announced the Grupo Cibest restructuring, and emphasized Nequi’s scale and future profitability. The main offset is that lower rates are expected to compress NIM.
Guidance delta
Management raised its outlook, with loan-growth guidance of 6.5% for 2024 and 7.2% for 2025; it also expects NIM to compress to 6% and cost of risk to fall to about 2%.
Key takeaways
- Management described improving macro conditions, including lower inflation and policy rates, alongside stronger credit quality and deposit growth.
- The planned Grupo Cibest structure is intended to reduce regulatory complexity and improve capital allocation.
- Nequi surpassed 20 million clients and remains a key future profit driver, though profitability timing remains a concern.
Management priorities
- Complete the transition to Grupo Cibest
- Accelerate consumer and mortgage loan growth
- Scale Nequi lending and digital services
- Keep expense growth below inflation
Follow CIB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Overweight | Downgrade | Sep 16, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 13, 2026 |
| B of A Securities | Neutral | Underperform | Upgrade | Jun 1, 2026 |
| UBS | Neutral | Neutral | Maintain | Apr 23, 2026 |
| Itau BBA | Underperform | Market Perform | Downgrade | Feb 26, 2026 |
| Citigroup | Neutral | Buy | Downgrade | Jan 22, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jan 28, 2025 |
| Credit Suisse | Outperform | Neutral | Upgrade | Aug 2, 2022 |
| HSBC | Buy | Hold | Upgrade | Feb 26, 2020 |
| Santander | Underperform | Hold | Downgrade | Nov 19, 2018 |
| Standpoint Research | Accumulate | Hold | Upgrade | Mar 7, 2018 |
| Deutsche Bank | Buy | Hold | Upgrade | Aug 22, 2016 |
| Barclays | Underweight | Underweight | Maintain | Mar 24, 2016 |
| Bank of America | Neutral | Buy | Downgrade | Mar 14, 2016 |
| BTG Pactual | Buy | Buy | Maintain | Feb 4, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $97.91. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Analyst unavailable | $110 | $95.79 | +12.3% | Aug 13, 2026 |
| RBC Capital | Analyst unavailable | $110 | $91.47 | +12.3% | Aug 11, 2026 |
| Goldman Sachs | Analyst unavailable | $98 | $87.93 | +0.1% | Jul 28, 2026 |
| UBS | Analyst unavailable | $72 | $73.65 | -26.5% | Apr 23, 2026 |
| Goldman Sachs | Analyst unavailable | $69 | $70.92 | -29.5% | Jan 13, 2026 |
| Banco Santander | Andres Soto | $61 | $61.83 | -37.7% | Dec 17, 2025 |
| Bank of America Securities | Ernesto Gabilondo | $34 | $33.12 | -65.3% | Aug 29, 2024 |
Track every rating change on CIB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationGrupo Cibest SA functions as an investment holding enterprise, with its headquarters situated in Medellin, Colombia.
Historical context
All CIB earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T Bank: Loan Growth Holds Up as Rates Pressure Margins |
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T: Deposit growth supports margins as AI use expands |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee Growth and Credit Quality Support Q3 |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee growth supports a steady Q3 outlook |
| TFC-PI Truist Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | -50.9% | — | Truist sharpens focus as Q3 EPS rises 12% |
| TRV The Travelers Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +24.2% | +1.5% | Travelers posts strong Q3, with investment income above $900 million |
Latest beats and misses
Who reports nextBeat on EPS
Get the CIB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-18T03:00:43.375703+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T03:00:43.372882+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.